Cargando…
Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease
BACKGROUND: Nausea is a major uremic symptom and a frequent indication for starting dialysis. However, preventive medication for uremic nausea has not yet been identified. Vitamin D receptor activators (VDRAs) may prevent uremic nausea via their pleiotropic actions. The objective of this study was t...
Autores principales: | Ikeda, Masato, Ueda, Yoshimi, Maruyama, Yukio, Yokoyama, Keitaro, Yokoo, Takashi, Joki, Nobuhiko, Ando, Ryoichi, Shinoda, Toshio, Inaguma, Daijo, Yamaka, Toshihiko, Komatsu, Yasuhiro, Koiwa, Fumihiko, Sakaguchi, Toshifumi, Negi, Shigeo, Shigematsu, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648733/ https://www.ncbi.nlm.nih.gov/pubmed/27844184 http://dx.doi.org/10.1007/s10157-016-1355-8 |
Ejemplares similares
-
Effect of erythropoietin-stimulating agent on uremic inflammation
por: Tanaka, Yuri, et al.
Publicado: (2012) -
False-negative diagnosis of high anion gap in patients with end-stage kidney disease
por: Komatsuzaki, You, et al.
Publicado: (2021) -
The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry
por: Maruyama, Yukio, et al.
Publicado: (2015) -
Excessive ADAM17 activation occurs in uremic patients and may contribute to their immunocompromised status
por: Yashiro, Mitsuru, et al.
Publicado: (2020) -
Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study
por: Inaguma, Daijo, et al.
Publicado: (2023)